Behavioural changes among post-myocardial infarction patients undergoing cardiac rehabilitation-medication therapy adherence clinic (CR-MTAC)

Research output: Contribution to journalArticle

Abstract

Cardiac rehabilitation management for post-myocardial infarction patients involves participation from multidisciplinary teams. Pharmacist contributions in influencing patients' outcome needs to be further explored. This study aimed to evaluate the behavioural impact of a pharmacist-managed Cardiac Rehabilitation-Medication Therapy Adherence Clinic (CR-MTAC) on post-myocardial infarction patients compared to Usual Care (UC). This was a cross-sectional, cohort observational study conducted between January and April 2011 at a tertiary public hospital. A total of 45 patients from CR-MTAC and 43 patients from UC were randomly selected and medical records were evaluated retrospectively for the past 2 years. All patients were under the care of physicians. The CR-MTAC group was counselled on non-pharmacotherapy and pharmacotherapy approach along with medications directly dispensed in the clinic by the pharmacist, while the UC group obtained the medications from the outpatient pharmacy. Behaviour changes were measured by medication adherence and assessed using Modified Morisky Scale (MMS) and A Single Question (ASQ). Baseline patient characteristics were similar between both groups. There was a higher percentage of adherent patients among CR-MTAC group at the end of the study in contrast to UC group using MMS (86.7 vs 41.9%, p<0.001) and ASQ (95.6 vs 53.5%, p<0.001). Patients with high adherence demonstrated better reduction of low density lipoprotein-c (LDL-c) level (p<0.001) post CR-MTAC intervention. Pharmacist intervention through CR-MTAC showed improvement in medication use behaviour changes among post-myocardial infarction patients compared to UC patients.

Original languageEnglish
Pages (from-to)646-651
Number of pages6
JournalInternational Journal of Pharmacy and Pharmaceutical Sciences
Volume4
Issue numberSUPPL.1
Publication statusPublished - 2012

Fingerprint

Medication Adherence
Myocardial Infarction
Pharmacists
Therapeutics
Patient Care
Patient Participation
Cardiac Rehabilitation
Public Hospitals
LDL Lipoproteins
Tertiary Care Centers
Medical Records
Observational Studies
Cohort Studies
Outpatients
Physicians
Drug Therapy

Keywords

  • Adherence clinic
  • Cardiac rehabilitation
  • Medication therapy
  • Myocardial infarction

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

@article{20413dbcd78d4a43b1a3413eca12b793,
title = "Behavioural changes among post-myocardial infarction patients undergoing cardiac rehabilitation-medication therapy adherence clinic (CR-MTAC)",
abstract = "Cardiac rehabilitation management for post-myocardial infarction patients involves participation from multidisciplinary teams. Pharmacist contributions in influencing patients' outcome needs to be further explored. This study aimed to evaluate the behavioural impact of a pharmacist-managed Cardiac Rehabilitation-Medication Therapy Adherence Clinic (CR-MTAC) on post-myocardial infarction patients compared to Usual Care (UC). This was a cross-sectional, cohort observational study conducted between January and April 2011 at a tertiary public hospital. A total of 45 patients from CR-MTAC and 43 patients from UC were randomly selected and medical records were evaluated retrospectively for the past 2 years. All patients were under the care of physicians. The CR-MTAC group was counselled on non-pharmacotherapy and pharmacotherapy approach along with medications directly dispensed in the clinic by the pharmacist, while the UC group obtained the medications from the outpatient pharmacy. Behaviour changes were measured by medication adherence and assessed using Modified Morisky Scale (MMS) and A Single Question (ASQ). Baseline patient characteristics were similar between both groups. There was a higher percentage of adherent patients among CR-MTAC group at the end of the study in contrast to UC group using MMS (86.7 vs 41.9{\%}, p<0.001) and ASQ (95.6 vs 53.5{\%}, p<0.001). Patients with high adherence demonstrated better reduction of low density lipoprotein-c (LDL-c) level (p<0.001) post CR-MTAC intervention. Pharmacist intervention through CR-MTAC showed improvement in medication use behaviour changes among post-myocardial infarction patients compared to UC patients.",
keywords = "Adherence clinic, Cardiac rehabilitation, Medication therapy, Myocardial infarction",
author = "{Mhd Ali}, Adliah and Nirmala Jagan and Saharuddin Ahmad",
year = "2012",
language = "English",
volume = "4",
pages = "646--651",
journal = "International Journal of Pharmacy and Pharmaceutical Sciences",
issn = "0975-1491",
publisher = "IJPPS",
number = "SUPPL.1",

}

TY - JOUR

T1 - Behavioural changes among post-myocardial infarction patients undergoing cardiac rehabilitation-medication therapy adherence clinic (CR-MTAC)

AU - Mhd Ali, Adliah

AU - Jagan, Nirmala

AU - Ahmad, Saharuddin

PY - 2012

Y1 - 2012

N2 - Cardiac rehabilitation management for post-myocardial infarction patients involves participation from multidisciplinary teams. Pharmacist contributions in influencing patients' outcome needs to be further explored. This study aimed to evaluate the behavioural impact of a pharmacist-managed Cardiac Rehabilitation-Medication Therapy Adherence Clinic (CR-MTAC) on post-myocardial infarction patients compared to Usual Care (UC). This was a cross-sectional, cohort observational study conducted between January and April 2011 at a tertiary public hospital. A total of 45 patients from CR-MTAC and 43 patients from UC were randomly selected and medical records were evaluated retrospectively for the past 2 years. All patients were under the care of physicians. The CR-MTAC group was counselled on non-pharmacotherapy and pharmacotherapy approach along with medications directly dispensed in the clinic by the pharmacist, while the UC group obtained the medications from the outpatient pharmacy. Behaviour changes were measured by medication adherence and assessed using Modified Morisky Scale (MMS) and A Single Question (ASQ). Baseline patient characteristics were similar between both groups. There was a higher percentage of adherent patients among CR-MTAC group at the end of the study in contrast to UC group using MMS (86.7 vs 41.9%, p<0.001) and ASQ (95.6 vs 53.5%, p<0.001). Patients with high adherence demonstrated better reduction of low density lipoprotein-c (LDL-c) level (p<0.001) post CR-MTAC intervention. Pharmacist intervention through CR-MTAC showed improvement in medication use behaviour changes among post-myocardial infarction patients compared to UC patients.

AB - Cardiac rehabilitation management for post-myocardial infarction patients involves participation from multidisciplinary teams. Pharmacist contributions in influencing patients' outcome needs to be further explored. This study aimed to evaluate the behavioural impact of a pharmacist-managed Cardiac Rehabilitation-Medication Therapy Adherence Clinic (CR-MTAC) on post-myocardial infarction patients compared to Usual Care (UC). This was a cross-sectional, cohort observational study conducted between January and April 2011 at a tertiary public hospital. A total of 45 patients from CR-MTAC and 43 patients from UC were randomly selected and medical records were evaluated retrospectively for the past 2 years. All patients were under the care of physicians. The CR-MTAC group was counselled on non-pharmacotherapy and pharmacotherapy approach along with medications directly dispensed in the clinic by the pharmacist, while the UC group obtained the medications from the outpatient pharmacy. Behaviour changes were measured by medication adherence and assessed using Modified Morisky Scale (MMS) and A Single Question (ASQ). Baseline patient characteristics were similar between both groups. There was a higher percentage of adherent patients among CR-MTAC group at the end of the study in contrast to UC group using MMS (86.7 vs 41.9%, p<0.001) and ASQ (95.6 vs 53.5%, p<0.001). Patients with high adherence demonstrated better reduction of low density lipoprotein-c (LDL-c) level (p<0.001) post CR-MTAC intervention. Pharmacist intervention through CR-MTAC showed improvement in medication use behaviour changes among post-myocardial infarction patients compared to UC patients.

KW - Adherence clinic

KW - Cardiac rehabilitation

KW - Medication therapy

KW - Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=84858959066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858959066&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 646

EP - 651

JO - International Journal of Pharmacy and Pharmaceutical Sciences

JF - International Journal of Pharmacy and Pharmaceutical Sciences

SN - 0975-1491

IS - SUPPL.1

ER -